Active - Proposal to Strike off
Company Information for CELL THERAPY ONCOLOGY LIMITED
CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS & TECHNOLOGY PARK, INNOVATION WAY, STRATFORD-UPON-AVON, CV37 7GZ,
|
Company Registration Number
![]() Private Limited Company
Active - Proposal to Strike off |
Company Name | |
---|---|
CELL THERAPY ONCOLOGY LIMITED | |
Legal Registered Office | |
CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS & TECHNOLOGY PARK INNOVATION WAY STRATFORD-UPON-AVON CV37 7GZ | |
Company Number | 10219539 | |
---|---|---|
Company ID Number | 10219539 | |
Date formed | 2016-06-07 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active - Proposal to Strike off | |
Lastest accounts | 31/07/2019 | |
Account next due | 30/04/2021 | |
Latest return | ||
Return next due | 05/07/2017 | |
Type of accounts | DORMANT |
Last Datalog update: | 2020-06-06 11:04:20 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
LEE PHILLIP CHAPMAN |
||
DAVID WILLIAM PRESTON |
||
TREVOR AJAN REGINALD |
||
SABENA SULTAN |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
MARK LEONARD WILLIAM HUGHES |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
CELL THERAPY DIABETES LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY TENDONCEL LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY SKINCEL LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY DIABETES LIMITED | Director | 2016-06-07 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY TENDONCEL LIMITED | Director | 2016-06-07 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY SKINCEL LIMITED | Director | 2016-06-07 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
HEARTCEL (JAPAN) LIMITED | Director | 2016-03-21 | CURRENT | 2016-03-21 | Active - Proposal to Strike off | |
CELL THERAPY LIMITED | Director | 2015-01-20 | CURRENT | 2009-07-23 | Active - Proposal to Strike off | |
NEUTRINO DEVELOPMENT LIMITED | Director | 2013-12-02 | CURRENT | 2012-11-06 | Dissolved 2014-11-18 | |
NEUTRINO BI LIMITED | Director | 2013-12-02 | CURRENT | 2011-09-06 | Dissolved 2015-08-25 | |
BIZ IMPACT GROUP LIMITED | Director | 2012-10-16 | CURRENT | 2012-10-16 | Dissolved 2014-03-25 | |
BIZAPP TECHNOLOGIES LIMITED | Director | 2012-03-21 | CURRENT | 2012-03-21 | Active - Proposal to Strike off | |
DAVID PRESTON LIMITED | Director | 2010-04-30 | CURRENT | 2009-02-09 | Active | |
CELIXIR LIMITED | Director | 2016-12-28 | CURRENT | 2016-12-28 | Active | |
CELL THERAPY DIABETES LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY TENDONCEL LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY SKINCEL LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY LIMITED | Director | 2012-06-01 | CURRENT | 2009-07-23 | Active - Proposal to Strike off | |
PEEPO GPS LTD | Director | 2010-02-20 | CURRENT | 2009-06-09 | Dissolved 2016-08-23 | |
CELL THERAPY DIABETES LIMITED | Director | 2016-06-21 | CURRENT | 2016-06-07 | Active - Proposal to Strike off | |
CELL THERAPY LIMITED | Director | 2015-01-20 | CURRENT | 2009-07-23 | Active - Proposal to Strike off |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as CELL THERAPY ONCOLOGY LIMITED are:
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |